Skip to main content

Table 3 Demographics and clinical characteristics for participating subjects (n = 245) – later clinical trial

From: A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials study

Characteristic

Lung cancer group (n = 111)

Control group (n = 134)

All (n = 245)

Age (years)a

67.9 ± 8.8

52.4 ± 13.5

59.4 ± 13.9

Sex

   

 Male

74

73

147

 Female

37

61

98

Smokers

   

 Current

61

47

108

 Formerb

30

18

48

Clinical stage

   

 I

39

–

–

 II

21

–

–

 III

25

–

–

 IV

25

–

–

 N/A

1

  

Histological type

   

 Adenocarcinoma

77

–

–

 Squamous cell carcinoma

21

–

–

 Other

13

–

–

  1. aThe age of subjects at blood withdrawal
  2. bSubjects with at least one pack-year in their history, who have not smoked in the past 30 days
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us